RESUMO
Despite sharing a similar genetic abnormality, patients with core binding factor acute myeloid leukemia (CBF-AML), which is characterized by the presence of t(8;21) or inv(16)/t(16;16), show heterogeneous survival. Other molecular or cytogenetic factors are supposed to have an impact on the prognosis. We enrolled 24 CBF-AML patients to determine the impact of cytogenetic abnormality, and c-KIT, FLT3, NPM1, and CEBPA mutations on the prognosis. Only three patients had the c-KIT mutation (3/24, 12.5%) and one had the FLT3 mutation. However, over half of the patients (14/24) harbored additional cytogenetic changes, including ten with loss of sexual chromosomes (LOS) [all in the t(8;21) group], and six had additional abnormalities (two cases had both LOS and additional abnormalities). From this small-number study, no association was found between c-KIT mutation and survival and relapse rate. However, additional chromosome abnormalities had a significant association with relapse of the disease (P = 0.027). Stem cell transplant had a trend of benefitting patients after relapse (P = 0.065). This implies that chromosome abnormalities occur in CBF-AML and might take part in the heterogeneous nature of CBF-AML.
Assuntos
Aberrações Cromossômicas , Fatores de Ligação ao Core/genética , Leucemia Mieloide Aguda/genética , Adulto , Idoso , Feminino , Humanos , Leucemia Mieloide Aguda/mortalidade , Masculino , Pessoa de Meia-Idade , Mutação , Nucleofosmina , Prognóstico , Proteínas Proto-Oncogênicas c-kit/genética , Adulto JovemRESUMO
Chromosome evolution is one of the major mechanisms of disease progression and resistance in chronic myeloid leukemia (CML) patients. However, the clinical significance of chromosomal evolution in the Philadelphia (Ph)-negative clone during therapy is not fully understood. We evaluated 94 CML patients in the chronic phase of CML during treatment of the disease. Six of them had Ph-negative chromosome abnormalities during treatment. Four patients with a single abnormality and a good molecular response showed no obvious complications from the chromosomal changes, while two other patients who had complex abnormalities and previous treatment had poor outcomes. Our results highlight the need for close monitoring of this kind of patient, not only on a molecular level but also at the cytogenetic level.
Assuntos
Células da Medula Óssea/citologia , Aberrações Cromossômicas , Leucemia Mieloide Crônica Atípica BCR-ABL Negativa/terapia , Transplante de Células-Tronco , Adulto , Idoso , Medula Óssea , Progressão da Doença , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Adulto JovemRESUMO
This report describes a retrospective analysis of case recordes of cutaneous larva migrans in Montserrat. An estimated incidence of 0.064% was found betweed mid-1977 and mid-1978
Assuntos
Humanos , Larva Migrans/epidemiologia , Índias OcidentaisRESUMO
Following the discovery in two villages in Montserrat of five individuals who were passing Schistosoma mansoni ova in their stools, a house to house survey was undertaken in November 1978 to determine the prevalence of the infection. From 158 persons residing in the two villages 137 faecal samples were received. Of these 14% were positive for S. mansoni ova. The enzyme linked immunosorbent assay (ELISA) was performed on finger-prick blood samples collected on chromatography paper. In the ELISA 16% of the 132 persons tested were positive. In comparison with the stool examination, the ELISA showed a 53% sensitivity and a 92% specificity. It was recommended that the individuals passing schistosome eggs should be treated.